Rees Heather 4
4 · ATOSSA THERAPEUTICS, INC. · Filed May 16, 2025
Insider Transaction Report
Form 4
Rees Heather
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-05-15+543,785→ 543,785 totalExercise: $0.99Exp: 2035-05-15→ Common Stock (543,785 underlying)
Footnotes (1)
- [F1]The options shall vest on a quarterly basis over 24 months following May 15, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date. The options were issued on May 15, 2025, with an exercise price of $0.99, representing the closing stock price on May 15, 2025.